Lansoprazole N-oxide
Lansoprazole N-oxide (Comound 2) is the overoxidized by-product found in the synthesis of the proton pump inhibitor Lansoprazole (HY-13662) . Lansoprazole N-oxide is promising for research of duodenal and gastric ulcers, reflux oesophagitis, and Zollinger–Ellison syndrome[1].
Product Specifications
CAS Number
[213476-12-1]
UNSPSC
12352005
Hazard Statement
H302-H315-H319-H335
Target
Drug Metabolite
Related Pathways
Metabolic Enzyme/Protease
Applications
Metabolism-protein/nucleotide metabolism
Field of Research
Metabolic Disease; Inflammation/Immunology
Smiles
O=S(C1=NC2=CC=CC=C2N1)CC3=C(C)C(OCC(F)(F)F)=CC=[N+]3[O-]
Molecular Formula
C16H14F3N3O3S
Molecular Weight
385.36
Precautions
P261-P264-P270-P271-P280-P302+P352-P304+P340-P330-P362+P364-P405-P501
References & Citations
[1]Reddy G M, et al. Synthesis and characterization of metabolites and potential impurities of lansoprazole, an antiulcerative drug[J]. Synthetic Communications®, 2008, 38 (20) : 3477-3489.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS6400363-01 0.1 mL
Cytokeratin 20 (Cytokeratin-20, CK 20, CK20, CK-20, Keratin 20, Keratin-20, K20, Keratin Type I Cytoskeletal 20, KRT20, KRT21, MGC35423, Protein IT) (Biotin)
Ask
View Details 
MBS6400363-02 5x 0.1 mL
Cytokeratin 20 (Cytokeratin-20, CK 20, CK20, CK-20, Keratin 20, Keratin-20, K20, Keratin Type I Cytoskeletal 20, KRT20, KRT21, MGC35423, Protein IT) (Biotin)
Ask
View Details 